Implications of vessel co-option in sorafenib-resistant hepatocellular carcinomaOACSCDCSTPCD
Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma
Elizabeth A.Kuczynski;Robert S.Kerbel
Sunnybrook Research Institute, 2075 Bayview Avenue, S-Wing, Room S217, Toronto, 0N M4N 3M5, CanadaSunnybrook Research Institute, 2075 Bayview Avenue, S-Wing, Room S217, Toronto, 0N M4N 3M5, Canada
Vessel co-optionNon-angiogenicResistanceSorafenibHepatocellular carcinoma
Vessel co-optionNon-angiogenicResistanceSorafenibHepatocellular carcinoma
《癌症(英文版)》 2016 (12)
641-644,4
评论